U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07729579) titled 'An Open-Label, Two-Cohort, Pharmacokinetic Study in a Maximal Use Setting for Patients With Actinic Keratosis on the Upper Extremities or the Face' on July 22.
Brief Summary: The research study will evaluate how the body absorbs and reacts to reformulated Levulan Kerastick when applied to actinic keratosis lesions (AKs) on the skin of the forearms or face followed by photodynamic therapy (PDT), a treatment that uses application of blue light.
Study Start Date: Aug. 04
Study Type: INTERVENTIONAL
Condition:
Actinic Keratosis (AK)
Intervention:
DRUG: Investigational drug
The study drug will be applied to the treatment area conta...